OakChart

NeuroOne Medical Technologies Corp

NMTCHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:44 PM ET

0.8024+0.0253 (3.26%)
2026-11-12 01:37 CET
Market cap
7.08 USD m
Revenue, TTM
9.47 USD m
Net income, TTM
-7.45 USD m
Free cash flow, TTM
-7.16 USD m
EPS diluted, TTM
-0.92
P/E
-
Compare

Price

NMTC against its 20, 50 and 200-day averages
2050200beatearnings
1.002.003.004.005.007.0M13.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NMTCclose 0.8020-day 0.9150-day 1.16200-day 3.020.80

86.9% under the 52-week high of 6.12 on 6 Jan 2026. 52-week low 0.75 on 10 Nov 2026. Last 15 sessions, 40.0% high to low

Volume 0.04× normal · the line is the 50-bar volume average

Profile

NMTC
52-week range, 1% of the way up
0.756.12

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Employees18
IPOJun 27, 2013
Beta0.92
ATR, 14d0.11
Rel volume0.04
Short float2.86%
Insider own20.39%
Inst own28.95%

Snapshot

6 groups

Valuation

Index-
Market Cap7.31M
Enterprise Value5.44M
Income-7.45M
Sales9.47M
Book/sh0.43
Cash/sh0.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees18
IPOJun 27, 2013

Ratios

P/E-
Forward P/E-
PEG-
P/S0.77
P/B1.85
P/C3.57
P/FCF-
EV/EBITDA-
EV/Sales0.57
Quick Ratio1.70
Current Ratio2.82
Debt/Eq0.05
LT Debt/Eq0.02
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.92
EPS next Y-0.63
EPS next Q-0.19
EPS this Y-32.10%
EPS next Y11.21%
EPS next 5Y14.29%
EPS past 3/5Y47.63% 48.67%
Sales past 3/5Y78.70% 44.41%
EPS Y/Y TTM7.34%
Sales Y/Y TTM-1.67%
EPS Q/Q-48.62%
Sales Q/Q16.34%
EarningsAug 19
EPS/Sales Surpr.0.00% 0.46%

Ownership

Insider Own20.39%
Insider Trans1.27%
Inst Own28.95%
Inst Trans-0.93%
ROA-87.56%
ROE-124.66%
ROIC-193.85%
Gross Margin55.65%
Oper. Margin-83.43%
Profit Margin-78.63%
SMA20-12.18%
SMA50-30.62%
SMA200-73.47%
Trades-

Technical

Shs Outstand8.70M
Shs Float7.25M
Short Float2.86%
Short Ratio0.61
Short Interest0.21M
52W High6.12 -86.89%
52W Low0.75 6.99%
Volatility14.53% 11.92%
ATR (14)0.11
RSI (14)35.98
Beta0.92
Rel Volume0.04
Avg Volume338.80K
Volume14,880

Performance

Perf Week-15.54%
Perf Month-27.05%
Perf Quarter-56.15%
Perf Half Y-82.21%
Perf YTD-82.36%
Perf Year-81.74%
Perf 3Y-89.87%
Perf 5Y-95.01%
Perf 10Y-91.89%
Recom1.00
Target Price7.27
Prev Close0.78
Price0.80
Change %3.26%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
May 05, 2025InitiatedLLadenburg ThalmannBuy$1.45+80.7%
Mar 29, 2022DowngradeCCraig HallumBuy → Hold$6 → $2+149.3%

Peers

Mkt cap
TickerCompanyMkt cap
CLPTClearPoint Neuro Inc293.94M
NPCENeuroPace Inc429.73M
CBLLCeribell Inc1.08B
MOBIMobia Medical Inc448.93M
ECORElectroCore Inc71.13M
NXLNexalin Technology Inc1.83M
ITGRInteger Holdings Corp4.31B
MDTMedtronic Plc129.98B
AMIXAutonomix Medical Inc2.90M
MBOTMicrobot Medical Inc74.55M

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Wambeke David J.Chief Business OfficerAug 27 '26Buy2.0133,33366,999199,999Sep 08 08:31 AM
Christianson MarkMarket Development DirectorJun 30 '26Sale3.1810,00031,77320,692Jul 02 04:39 PM
Christianson MarkOfficerJun 30 '26Proposed Sale3.3410,00033,400Jun 30 09:02 AM
Christianson MarkBusiness Development DirectorMar 30 '26Sale0.7415,36311,369198,920Apr 01 04:11 PM
Christianson MarkBusiness Development DirectorMar 12 '26Sale0.80817654214,383Mar 16 03:30 PM
Christianson MarkBusiness Development DirectorMar 13 '26Sale0.8010080214,283Mar 16 03:30 PM
Christianson MarkBusiness Development DirectorMar 10 '26Sale0.8011,6119,289217,309Mar 12 03:58 PM
Christianson MarkBusiness Development DirectorMar 11 '26Sale0.802,1091,687215,200Mar 12 03:58 PM
Christianson MarkOfficerMar 09 '26Proposed Sale0.8430,00025,200Mar 09 02:57 PM
Wambeke David J.Chief Business OfficerMar 01 '26Buy0.671,000,000670,4001,000,000Mar 03 08:49 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-08-19-0.230-0.230-0.2301.981.973
2026Q22026-05-12-0.250-0.227-0.2502.392.583
2026Q12026-02-17-0.177-0.240-0.1712.892.662
2025Q42025-12-17-0.300-0.240-0.1942.722.472
2025Q32025-08-14-0.180-0.300-0.1851.701.821
2025Q22025-05-13-0.420-0.540-0.4381.391.271
2025Q12025-02-120.360-0.3476.30--
2024Q42024-12-17-0.660--0.6720.83--
2024Q32024-08-14-0.600--0.6070.83--
2024Q22024-05-14-0.660-0.540-0.6611.381.201
2024Q12024-02-13-0.840-0.840-0.8360.980.852
2023Q42023-12-14-1.027-1.050-0.8000.740.802
2023Q32023-08-14-1.200-1.230-1.1840.630.342
2023Q22023-05-11-1.260-1.230-1.2880.470.232
2023Q12023-02-14-0.660-0.930-0.6411.570.952
2022Q42022-12-22-0.480-0.660-0.5092.011.802

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-5.580-6.270-5.5800.200.20
2022FY-3.780-3.900-3.7502.121.90
2023FY-3.900-4.170-3.9273.413.50
2024FY-2.760--2.7623.45-
2025FY-0.540-0.690-0.5409.108.90
2026FY--0.713--9.95
2027FY--0.633--13.33
2028FY--0.340--18.19
2029FY-0.360--28.71
2030FY-0.620--35.80

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-023103.192.603.80
2026Q4S2026-10-273113.192.603.80
2026Q4S2026-10-053123.192.603.80
2026Q4S2026-08-193032.792.603.18
2026Q4S2026-08-133022.812.603.18
2026Q4S2026-07-263003.022.653.56
2026Q4S2026-05-123023.022.653.56
2026Q4S2026-05-033003.192.863.73
2026Q4S2026-02-273113.192.863.73
2026Q4S2026-02-172113.292.863.73
2026Q4S2025-12-262103.412.704.11
2026Q4S2025-12-171002.702.702.70
2026Q4S2025-11-112003.252.703.80
2026Q4S2025-11-102003.252.703.80

Estimate history

EPS, annual-13.86-14.58-10.294-15.113-5.58-3.75-3.927-2.762-0.539-0.9219
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.607-0.6720.347-0.438-0.185-0.194-0.171-0.281-0.275
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0001.9270.2432.123.4083.45312.0989.47
Period201720182019202020212022202320242025TTM
Sales, quarterly0.8260.2726.2741.3871.6962.7412.8931.8621.973
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.4370.5360.751.2322.0022.7033.9885.1368.3348.703
Period201720182019202020212022202320242025MRQ
Shares, quarterly4.6415.1365.145.2318.3048.3348.4028.6168.703
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue9.4712.103.453.412.120.241.930.000.00
Cost of Goods Sold Incl. D&A4.203.962.371.500.240.280.070.030.02
Gross Profit5.278.141.081.911.88-0.031.86-0.03-0.02
Selling, General and Administrative Excl. Other13.1712.3712.9713.8711.2510.196.765.794.49
Research and Development5.404.985.076.944.933.932.081.530.95
Other Operating Expense0.000.000.000.000.000.000.000.00-1.30
Operating Income-7.90-4.23-11.89-11.96-9.37-10.22-4.90-5.81-3.21
Interest Expense0.000.330.230.000.000.007.520.281.01
Unusual Expense-0.31-0.780.330.000.66-0.271.210.680.98
Net Income Before Taxes-7.45-3.61-12.32-11.86-10.00-9.95-13.64-6.78-6.83
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-7.45-3.61-12.32-11.86-10.00-9.95-13.64-6.78-6.83
Net Income From Continuing Operations-7.45-3.61-12.32-11.86-10.00-9.95-13.64-6.78-6.83
Net Income-7.45-3.61-12.32-11.86-10.00-9.95-13.64-6.78-6.83
EPS (Recurring)-0.92-0.62-2.71-3.93-3.58-5.69-14.17-9.57-13.13
EPS (Basic, Before Extraordinaries)-0.88-0.54-2.76-3.93-3.75-5.58-15.11-10.29-14.58
EPS (Diluted)-0.92-0.54-2.76-3.93-3.75-5.58-15.11-10.29-14.58
EBITDA-7.66-3.96-11.64-11.76-9.14-10.07-4.83-5.79-3.19
Non-Operating Income (Expense)0.150.170.130.100.030.000.000.00-1.62
Other After Tax Adjustments0.000.000.000.000.000.000.000.00-
Stock Option Compensation Expense1.411.261.341.110.951.791.840.490.65
Price To Sales Ratio2.812.957.674.7312.75173.9110.84--
Gross Margin55.6567.3031.2756.1088.59-13.5696.34--
Operating Margin-83.43-34.94-344.26-350.84-441.84-4,205.75-254.46--
Net Margin-78.63-29.80-356.74-348.03-471.67-4,094.60-708.00--
Shares Outstanding8.708.335.143.992.702.001.230.750.54
Market Capitalization7.087.0830.5115.9027.4147.4428.5025.2336.07

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1.971.862.892.741.701.396.270.27
Cost of Goods Sold Incl. D&A0.790.871.321.210.780.621.350.13
Gross Profit1.180.991.571.530.910.774.930.14
Selling, General and Administrative Excl. Other3.613.393.282.902.803.453.222.96
Research and Development1.431.471.391.121.181.511.171.11
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.42-2.40-1.71-1.37-1.89-2.681.71-2.82
Interest Expense0.000.000.000.000.010.000.320.23
Unusual Expense-0.410.01-0.220.31-0.32-0.39-0.390.33
Net Income Before Taxes-2.01-2.38-1.44-1.62-1.50-2.271.79-3.35
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-2.01-2.38-1.44-1.62-1.50-2.271.79-3.35
Net Income From Continuing Operations-2.01-2.38-1.44-1.62-1.50-2.271.79-3.35
Net Income-2.01-2.38-1.44-1.62-1.50-2.271.79-3.35
EPS (Recurring)-0.31-0.28-0.19-0.17-0.21-0.490.29-0.63
EPS (Basic, Before Extraordinaries)-0.23-0.28-0.17-0.19-0.19-0.440.35-0.67
EPS (Diluted)-0.28-0.28-0.17-0.19-0.19-0.440.35-0.67
EBITDA-2.38-2.34-1.64-1.31-1.82-2.611.78-2.75
Non-Operating Income (Expense)0.010.020.050.070.080.020.010.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.350.340.360.360.320.250.340.34
Price To Sales Ratio2.814.304.383.673.423.022.918.58
Gross Margin59.9453.1854.2055.7753.9455.6178.5351.81
Operating Margin-122.87-128.74-59.02-50.02-111.23-193.2927.27-1,034.48
Net Margin-101.68-127.92-49.71-59.08-88.49-163.7628.46-1,230.55
Shares Outstanding8.708.628.408.338.305.235.145.14
Market Capitalization7.0840.1438.2144.4433.8026.6825.4730.51

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.571.465.3211.146.904.040.260.010.03
Short Term Receivables1.260.180.000.030.050.000.000.000.00
Inventories2.232.641.730.700.100.000.000.000.00
Other Current Assets0.140.220.260.300.150.120.040.010.01
Total Current Assets10.204.497.3112.187.204.160.300.020.03
Net Property, Plant & Equipment0.510.670.690.530.510.450.050.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable-------0.00-
Intangible Assets0.040.070.090.110.130.160.180.200.22
Deferred Tax Assets0.09--------
Other Assets0.020.140.000.000.090.000.000.000.00
Total Assets10.885.378.1012.827.944.760.530.220.25
Short Term Debt Incl. Current Port. of LT Debt0.120.070.130.080.111.070.001.682.42
Accounts Payable1.011.030.690.930.530.760.00-0.00
Other Current Liabilities1.171.120.982.090.540.531.772.121.48
Total Current Liabilities2.302.211.793.101.182.361.773.803.91
Long Term Debt0.140.190.060.120.200.340.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00-0.00
Deferred Tax Liabilities0.09--------
Other Liabilities1.272.140.000.000.000.000.000.821.38
Total Liabilities3.814.551.853.221.382.691.774.615.29
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7.070.826.259.606.552.07-1.24-4.40-5.04
Total Shareholders Equity7.070.826.259.606.552.07-1.24-4.40-5.04
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7.070.826.259.606.552.07-1.24-4.40-5.04
Total Liabilities & Stockholders Equity10.885.378.1012.827.944.760.530.220.25
Book Value Per Share0.850.161.573.553.271.68-1.65-8.19-11.53
Tangible Book Value Per Share0.840.151.543.513.211.55-1.89-8.57-12.02
Full-Time Employees18171615114433
Price to Book Ratio1.8037.114.062.857.2413.79-20.39-4.95-8.92
Return on Assets-44.38-182.93-113.38-96.33-156.69-515.46-1,805.10-2,913.04-3,978.91
Return on Equity-91.34-348.39-149.61-123.77-230.81-3,292.36---
Return on Invested Capital-49.97-1,211.93-188.11-102.84-147.23-567.43---
Quick Ratio3.460.843.123.706.011.760.170.000.01
Current Ratio4.432.034.083.936.091.760.170.000.01

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-7.45-3.61-12.32-11.86-10.00-9.95-13.64-6.78-
Depreciation0.240.260.250.200.230.150.070.03-
Other Funds (Non Cash)1.230.642.011.201.041.7110.571.46-
Funds from Operations-5.98-2.71-10.06-10.46-8.73-8.09-3.00-5.29-
Extraordinary Item0.000.000.000.000.000.000.000.00-
Changes in Working Capital-1.07-0.43-0.95-2.431.21-0.51-0.43-0.10-
Cash from Operating Activities-7.05-3.14-11.01-12.89-7.52-8.61-3.43-5.40-
Capital Expenditures-0.11-0.08-0.12-0.38-0.28-0.07-0.12-0.12-
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.010.000.000.000.00-
Purchase or Sale of Investments0.000.000.003.03-2.970.000.000.00-
Purchase of Investments0.000.000.00-1.47-3.470.000.000.00-
Sale Or Maturity of Investments0.000.000.004.500.500.000.000.00-
Other Uses0.000.000.000.000.000.000.000.00-
Other Sources0.000.000.000.000.000.000.000.00-
Cash from Investing Activities-0.11-0.08-0.122.65-3.24-0.07-0.12-0.12-
Cash Dividends Paid0.000.000.000.000.000.000.000.00-
Change in Capital Stock1.178.337.347.4012.0211.540.016.05-
Repurchase of Common Pref Stock-0.07-0.12-0.08-0.120.000.000.000.00-
Sale of Common Pref Stock1.248.457.437.5212.0211.540.016.05-
Proceedsfrom Stock Options1.008.385.617.5212.0211.250.015.58-
Issuance or Reduction of Debt, Net0.000.000.000.000.000.007.32-0.28-
Change in Long Term Debt0.000.000.000.000.000.00-1.040.00-
Issuance of Long Term Debt0.000.000.000.000.000.00-1.040.00-
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00-
Net Financing Active Other Cash Flow0.000.00-0.070.000.000.000.000.00-
Other Financing Activities Uses0.000.00-0.070.000.000.000.000.00-
Cash from Financing Activities1.178.337.277.4012.0211.547.325.77-
Net Change in Cash-5.995.11-3.86-2.841.262.863.780.25-
Free Cash Flow-7.16-3.22-11.13-13.27-7.79-8.67-3.55-5.45-
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00-

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments2.052.803.566.578.041.32
Short Term Receivables1.101.902.661.260.000.32
Inventories2.292.101.672.231.901.83
Other Current Assets0.320.280.150.140.230.21
Total Current Assets5.767.088.0410.2010.173.68
Net Property, Plant & Equipment0.370.430.470.510.600.65
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.030.030.040.040.050.06
Deferred Tax Assets---0.09--
Other Assets0.030.020.020.020.000.07
Total Assets6.197.578.5810.8810.824.46
Short Term Debt Incl. Current Port. of LT Debt0.100.110.130.120.120.10
Accounts Payable0.910.930.551.010.470.91
Other Current Liabilities1.030.640.581.170.840.75
Total Current Liabilities2.041.691.262.301.431.76
Long Term Debt0.070.090.110.140.180.21
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---0.09--
Other Liabilities0.300.710.811.271.041.36
Total Liabilities2.422.492.183.812.643.33
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3.775.086.407.078.181.13
Total Shareholders Equity3.775.086.407.078.181.13
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3.775.086.407.078.181.13
Total Liabilities & Stockholders Equity6.197.578.5810.8810.824.46
Book Value Per Share0.430.590.760.850.980.22
Tangible Book Value Per Share0.430.590.760.840.980.20
Full-Time Employees---18--
Price to Book Ratio1.807.915.976.284.1323.70
Return on Assets-87.56-115.42-90.61-44.38-67.85-134.06
Return on Equity-124.66-223.76-146.27-91.34-95.39-265.18
Return on Invested Capital-52.24-46.08-22.08-22.44-17.97-170.36
Quick Ratio1.702.955.073.465.801.05
Current Ratio2.824.196.394.437.132.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-2.01-2.38-1.44-1.62-1.50-2.27
Depreciation0.050.060.070.060.070.07
Other Funds (Non Cash)-0.020.380.170.700.04-0.12
Funds from Operations-1.98-1.94-1.21-0.85-1.39-2.32
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.900.61-1.91-0.68-0.072.26
Cash from Operating Activities-1.08-1.33-3.12-1.53-1.46-0.06
Capital Expenditures-0.02-0.04-0.04-0.01-0.04-0.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.02-0.04-0.04-0.01-0.04-0.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.350.610.150.078.230.07
Repurchase of Common Pref Stock-0.00-0.06-0.00-0.00-0.00-0.11
Sale of Common Pref Stock0.350.670.150.078.230.17
Proceedsfrom Stock Options0.350.67-0.02-1E-068.230.17
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.19
Other Financing Activities Uses0.000.000.000.000.000.19
Cash from Financing Activities0.350.610.150.078.230.25
Net Change in Cash-0.76-0.76-3.01-1.476.720.19
Free Cash Flow-1.10-1.37-3.16-1.54-1.51-0.07

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 3.45M 2025: 9.10M
United States2024: 3.45M 2025: 9.10M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.86%0.2M7.3M342.39K
2026-10-152.86%0.2M7.3M333.53K
2026-09-302.47%0.2M7.3M312.47K
2026-09-151.05%0.1M7.3M296.67K
2026-08-313.37%0.2M7.2M278.20K
2026-08-141.14%0.1M7.2M49.13K
2026-07-310.56%0.0M6.9M38.98K
2026-07-150.18%0.0M6.9M42.69K
2026-06-300.39%0.0M7.3M39.60K
2026-06-150.58%0.0M7.3M36.69K
2026-05-290.47%0.0M7.2M40.22K
2026-05-150.63%0.0M7.2M40.34K
2026-04-300.39%0.0M7.1M39.74K
2026-04-150.30%0.0M7.7M38.00K
2026-03-310.25%0.0M7.9M42.71K
2026-03-130.18%0.0M7.9M48.77K
2026-02-270.23%0.0M7.9M47.85K
2026-02-130.44%0.0M7.9M45.80K
2026-01-300.16%0.0M7.8M44.80K
2026-01-150.11%0.0M7.8M45.57K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.750.0426.90114.000.000.966-0.0140.000
call5.000.000.750.0028.4820.000.000.964-0.0160.000
call7.500.000.750.0029.3480.000.000.964-0.0170.000
put2.501.352.100.0013.1830.000.00-0.034-0.0140.000
put5.003.604.800.0020.6050.000.00-0.036-0.0150.000
put7.506.007.500.000.0000.000.00-0.036-0.0160.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-058-KCurrent report2026-10-05SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-278-KCurrent report2026-08-27SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-07-143Initial statement of beneficial ownership of securities2026-07-10SEC
2026-07-14SCHEDULE 13G/ASEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-30144Filing for proposed sale of securities under Rule 144.SEC
2026-06-12424B5SEC
2026-06-128-KCurrent report2026-06-12SEC
2026-06-1210-Q/A2026-03-31SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-228-KCurrent report2026-05-21SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-048-KCurrent report2026-04-30SEC
2026-04-308-KCurrent report2026-04-24SEC
2026-04-21SCHEDULE 13GSEC
2026-04-148-KCurrent report2026-04-14SEC
2026-04-074Statement of changes in beneficial ownership of securities2026-04-03SEC
2026-04-074Statement of changes in beneficial ownership of securities2026-04-03SEC
2026-04-074Statement of changes in beneficial ownership of securities2026-04-03SEC
2026-04-074Statement of changes in beneficial ownership of securities2026-04-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0867.00K100
2026-070000
2026-060031.77K1
2026-050000
2026-040000
2026-03670.40K123.08K5
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Bleichroeder LP7.66%
VANGUARD CAPITAL MANAGEMENT LLC4.05%
BARD ASSOCIATES INC3.51%
PERKINS CAPITAL MANAGEMENT INC1.76%
GEODE CAPITAL MANAGEMENT, LLC1.03%
Sio Capital Management, LLC0.95%
RENAISSANCE TECHNOLOGIES LLC0.81%
VANGUARD FIDUCIARY TRUST CO0.56%
ESSEX INVESTMENT MANAGEMENT CO LLC0.50%
Cambridge Investment Research Advisors, Inc.0.32%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.93%
VANGUARD EXTENDED MARKET INDEX FUND1.04%
Fidelity Extended Market Index Fund0.49%
iShares Micro-Cap ETF0.27%
Fidelity Total Market Index Fund0.15%
Fidelity Series Total Market Index Fund0.13%
VANGUARD BALANCED INDEX FUND0.09%
Fidelity Nasdaq Composite Index Fund0.05%
1290 VT Micro Cap Portfolio0.02%

OakChart. NMTC. Cached 15 minutes.